The first person who introduced the concept of “stalking” in investing was Van Tharp when he described his Ten Tasks of Trading. One of these tasks was: “stalking your trade”. Just like a cat stalks its prey looking for the best possible moment to pounce, so a trader can stalk an entry to get the best price for entry.
It was becoming obvious at about this time in 2007 that something very bad was happening in America’s banks. Air was rushing out of the US housing market bubble and the country’s banks, mortgage providers and brokers were bearing the brunt of the blast.
One of the biggest sub-prime lenders in the US, New Century Financial, had already filed for bankruptcy. Bear Stearns would soon bail out one of its hedge funds that was exposed to the US housing market to the tune of $3.2bn. The bank would be forced to liquidate it a month later. As we now know, what started in the US would spread around the world.
Part of the crisis response has been to rewrite the global bank rulebook. Much of this has been sensible. This has made them safer to the kind of capital flight that did for them in the crisis. Big capital buffers should mean that the largest banks will not need to turn to taxpayers if there is a repeat of the conditions of the financial crisis.
– The economy continues to decelerate gradually to a more sustained speed of around 5% in the medium term. It is expected to slow in Q2 17, but also to transform itself toward more consumption and services
– Beyond the growth objectives, the authorities are looking to curb financial excesses and to diversify in and outflows channels. State Owned Enterprises (SOE) restructuring remains the weak link of the current reforms
Biotechnology is defined as the use of living systems and organisms to develop or make products, or "any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use" (UN Convention on Biological Diversity). The recent dramatic improvements and progresses in research and achievements in this sector reveal a considerable potential for the improvement of the quality of life but also for the creation of economic value. Therefore, biotech can be considered as key industry for the century.
Swiss bank Swissquote is the first online bank to launch Bitcoin trading. The company is pioneering a new product for the brokerage industry, choosing to launch trading in the virtual currency without leverage. Now, clients will be able to exchange euros and US dollars into Bitcoin using their trading accounts.
The lack of leverage in Swissquote’s offering represents a great alternative to unregulated exchanges for clients of the Swiss brokerage. Demand for trading cryptocurrencies has been slowly picking up amongst retail traders in recent months. As the popularity of the new asset class has been growing, several retail brokers have started offering CFDs on Bitcoin.
In a major event for Swiss banking and Bitcoin generally, Falcon Private Bank became the first Swiss bank to begin offering customers direct access to their Bitcoin and altcoin portfolios. Through a partnership with Bitcoin Suisse AG, the bank is able to provide the necessary infrastructure to allow clients access to their coin holdings.
Wealthy clients of Swiss private bank Falcon will be able to store and trade bitcoins via their cash holdings with the bank from Wednesday, a move that signals the traction the virtual currency is gaining even in slow-changing asset management.
Robots are moving on to the trading floors of investment banks. Many of the world’s biggest banks have for years been automating manual, repetitive tasks done by support staff to save money. But now they are putting the latest forms of artificial intelligence to work at the heart of operations among their star traders, allocating funds and analysing data to develop strategies.
According to a report by the Financial Times, UBS is about to take robots to trading floors. The company has shown how two AI solutions can assist traders in enhancing their performance.
For qualified investors / professional clients only
In order to proceed, you must confirm that you are a qualified investor based in Switzerland
The information contained in this section have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document.
Before investing in a product please read the latest prospectus carefully and thoroughly and note that funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided without any guarantee or warranty and are for the recipient's personal use and information purposes only